ARTICLE | Company News
Elixir Medical sales and marketing update
January 20, 2014 8:00 AM UTC
Elixir launched its DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System in Europe to treat coronary artery disease (CAD). The scaffold is available in diameters of 3, 3.25 and 3.5 mm and...